These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7150366)

  • 1. Biochemical pharmacology of acivicin in rat hepatoma cells.
    Lui MS; Kizaki H; Weber G
    Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
    Weber G; Prajda N; Lui MS; Denton JE; Aoki T; Sebolt J; Zhen YS; Burt ME; Faderan MA; Reardon MA
    Adv Enzyme Regul; 1982; 20():75-96. PubMed ID: 6180609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
    Denton JE; Lui MS; Aoki T; Sebolt J; Weber G
    Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma.
    Aoki T; Sebolt J; Weber G
    Biochem Pharmacol; 1982 Mar; 31(6):927-32. PubMed ID: 7082374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo inactivation of formylglycinamidine ribonucleotide synthetase in rat hepatoma.
    Elliott WL; Weber G
    Biochem Pharmacol; 1985 Jan; 34(2):243-8. PubMed ID: 3966925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation by acivicin of rat brain CTP and GMP synthetases and depression of CTP and GTP concentrations.
    Achleitner E; Lui MS; Weber G
    Adv Enzyme Regul; 1985; 24():225-32. PubMed ID: 3835820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acivicin and dipyridamole on hepatoma 3924A cells.
    Zhen YS; Lui MS; Weber G
    Cancer Res; 1983 Apr; 43(4):1616-9. PubMed ID: 6831407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of antimetabolite action by dibromodulcitol in cell culture.
    Oláh E; Kremmer T; Boldizsár M
    Adv Enzyme Regul; 1985; 24():155-75. PubMed ID: 3835819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme targets of antiglutamine agents in cancer chemotherapy.
    Prajda N
    Adv Enzyme Regul; 1985; 24():207-23. PubMed ID: 2424283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Jayaram HN; Ardalan B; Deas M; Johnson RK
    Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage capacity of hepatoma 3924A and action of dipyridamole.
    Weber G; Lui MS; Natsumeda Y; Faderan MA
    Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.
    Sebolt JS; Aoki T; Eble JN; Glover JL; Weber G
    Biochem Pharmacol; 1985 Jan; 34(1):97-100. PubMed ID: 3966920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501).
    Meck RA; Clubb KJ; Allen LM; Yunis AA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4547-53. PubMed ID: 7306976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined action of acivicin and D-galactosamine on pyrimidine nucleotide metabolism in hepatoma cells.
    Leube K; Keppler DO
    Biochem Pharmacol; 1983 Jun; 32(12):1865-9. PubMed ID: 6882463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
    Fischer PH; Pamukcu R; Bittner G; Willson JK
    Cancer Res; 1984 Aug; 44(8):3355-9. PubMed ID: 6744269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of the activities of IMP dehydrogenase and GMP synthase after treatment with tiazofurin and acivicin in hepatoma cells in vitro.
    Ikegami T; Natsumeda Y; Weber G
    Adv Exp Med Biol; 1989; 253B():299-304. PubMed ID: 2575350
    [No Abstract]   [Full Text] [Related]  

  • 18. Acivicin inhibits Crithidia fasciculata growth in a serum-free medium and inactivates carbamoyl-phosphate synthetase II in vivo.
    Aoki T; Oya H
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):391-6. PubMed ID: 2902999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
    Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
    Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin.
    Nichols KE; Chitneni SR; Moore JO; Weinberg JB
    Blood; 1989 Oct; 74(5):1728-37. PubMed ID: 2790198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.